##plugins.themes.bootstrap3.article.main##

Wendy Lizeth Mendoza Jamanca Carmen Rosa Dávila Aliaga Pilar Medina Alva Rosa Alvarado Merino

Abstract

ABSTRACT
Maple syrup urine disease is a congenital metabolic disorder, commonly presenting as acute neonatal encephalopathy.
Case 1. A 7-day-old neonate exhibited somnolence and refusal to breastfeed, later developing respiratory failure, neurological impairment, metabolic acidosis, and death. Elevated levels of branched-chain amino acids and a confirmatory
genetic test established the diagnosis. Case 2. A 10-day-old neonate was admitted with breastfeeding refusal, hypoglycemia, and seizures. Elevated branched-chain amino acids confirmed the diagnosis genetically. The patient received
parenteral nutrition and a special formula, leading to progressive neurological improvement. Currently, at 2 years and 7
months, the patient remains under multidisciplinary follow-up. Conclusion. Early detection of maple syrup urine disease
through neonatal screening significantly improves neurological outcomes. 

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

Section
Case Report

How to Cite

Mendoza Jamanca, W. L., Dávila Aliaga, C. R., Medina Alva, P., & Alvarado Merino, R. (2024). MAPLE SYRUP URINE DISEASE: REPORT OF TWO CASES. Revista Peruana De Investigación Materno Perinatal, 13(2), 39–43. https://doi.org/10.33421/inmp.2024391